journal article·2026-06Open access

Biomimetic Folate-Targeted Lanthanide-Doped Gold Nanoparticles as Imaging Probes for Dual-Mode Spectral Photon-Counting CT and T2-Weighted Magnetic Resonance Imaging

Yusuf O. Ibrahim, Nabil Maalej, Ahsanulhaq Qurashi, Mohamed Rahmani, Osama Abdullah, Gobind Das, Rasha A. Nasser, Charalampos Pitsalidis, Mira Mousa, Rainer Straubinger, Aamir Younis Raja

Abstract

Multifunctional nanoparticles (MNPs) have enormous potential for multimodal cancer imaging and effective targeted delivery of cancer. Herein, folate-targeted Au/lanthanide (FAB@Au/Ln-DTPA, Ln = Dy, Ho, Er) nanoparticles (NPs) were developed as dual-mode contrast agents for spectral photon-counting computed tomography (SPCCT) and magnetic resonance imaging (MRI). The NPs were synthesized using folic acid (FA) as targeting ligands and BSA as a bio-template. TEM imaging confirmed that the NPs are spherical with a narrow size distribution (12.2–13.6 nm). Biocompatibility assays conducted with MDA-MB-231 and A549 cell lines, and hemolysis with human red blood cells, demonstrated low cytotoxicity and hemocompatibility (IC50 > 300 μg/mL), indicating excellent biocompatibility. SPCCT imaging revealed a dual K-edge X-ray contrast arising from the combination of Au and Ln elements. MRI results showed relaxivity values of 36.65, 32.01, and 31.67 mM −1 s −1 for FAB@Au/Dy-DTPA, FAB@Au/Ho-DTPA, and MDAMB-23-DTPA, respectively, indicating T 2 -weighted contrast enhancement. Cellular uptake analysis revealed greater internalization in MDA-MB-231 cells than in A549 cells, suggesting folate receptor-mediated uptake. In general, FAB@Au/Ln-DTPA nanoparticles demonstrated high potential as a biocompatible dual-modality imaging agent for spectral photon-counting CT and magnetic resonance imaging, with targeting capability for imaging cancer cells overexpressing folate receptors. These nanoparticles can serve as a delivery vehicle for future imaging-guided therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Nanoplatforms for cancer theranostics · Advanced X-ray and CT Imaging

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (81)

Show source-provided references
1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and global burden of disease study
3. Sera · 2021 · 167
4. Klein · 2024 · 1
5. Photon-counting CT systems: a technical review of current clinical possibilities, Diagn
6. Spectral photon-counting computed tomography: a review on technical principles and clinical applications10.3390/jimaging8040112 ↗
7. Spectral photon-counting computed tomography: technical principles and applications in the assessment of cardiovascular diseases10.3390/jcm13082359 ↗
8. Recent advances in magnetic resonance imaging for the diagnosis of liver cancer: a comprehensive review10.3390/diagnostics15162016 ↗
9. Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: literature review10.1016/j.ejro.2023.100503 ↗
10. Gadolinium deposition disease: a new risk management threat10.1016/j.jacr.2019.11.009 ↗
11. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward10.1007/s00330-023-10281-3 ↗
12. Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in Male mice10.1186/s12951-022-01291-2 ↗
13. Monodispersed ultrathin GdF3 nanowires: oriented attachment, luminescence, and relaxivity for MRI contrast agents10.1039/c2jm34987f ↗
14. HoF3 and DyF3 nanoparticles as contrast agents for high-field magnetic resonance imaging10.1002/ppsc.201700116 ↗
15. Terbium-doped manganese carbonate nanoparticles with intrinsic photoluminescence and magnetic resonance imaging capacity10.1016/j.jcis.2016.09.010 ↗
16. NMR transversal relaxivity of suspensions of lanthanide oxide nanoparticles10.1021/jp072288l ↗
17. Molecular imaging for biomimetic nanomedicine in cancer therapy: current insights and challenges10.1021/acsami.4c19720 ↗
18. Vision 20/20: simultaneous CT-MRI — next chapter of multimodality imaging10.1118/1.4929559 ↗
19. Fusion of CT and MRI modalities for brain tumors classification using enhanced machine vision framework10.1016/j.asej.2025.103669 ↗
20. CT and MRI image fusion via multimodal feature interaction network10.1007/s13721-024-00449-2 ↗
21. Multi-Modal image fusion for medical diagnosis: combining MRI and CT using deep generative models10.18535/cmhrj.v5i03.486 ↗
22. Jiang · 2023 · vol. 13
23. Harnessing nanotechnology for cancer treatment10.3389/fbioe.2024.1514890 ↗
24. Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis10.2147/IJN.S378074 ↗
25. Comparison of gold nanoparticles and iodinated contrast media in radiation dose reduction and contrast enhancement in computed tomography, Iran
26. Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer10.7150/jca.19786 ↗
27. Novel contrast agents for Spectral photon counting computed tomography (SPCCT)
28. Biodegradable poly(amino acid)–bismuth nanotheranostic agents for CT/MR imaging and photothermal–chemodynamic synergistic therapy
29. Hariyadi, enhancing biomedical imaging: the role of nanoparticle-based contrast agents10.1007/s10544-024-00725-y ↗
30. Dual-imaging nanoparticles based on surface-modified magnetic nanoparticles and biodegradable photoluminescent polymers10.3389/fbioe.2025.1558817 ↗
31. Magnetic nanoparticle-polymer nanocomposites for enhanced magnetic resonance imaging (MRI) contrast agents: a review10.1134/S106378262460222X ↗
32. Novel advancements in nanomaterials-based contrast agents across multimodal imaging and theranostic applications10.1039/D5NA00596E ↗
33. Development and characterization of new contrast agents for photon-counting CT10.1016/j.ejrad.2025.112643 ↗
34. Color K-edge angiography with a dedicated gadolinium-based contrast agent for spectral photon-counting computed tomography10.1016/j.diii.2025.07.001 ↗
35. Energy-sensitive photon counting detector-based X-ray computed tomography10.1007/s12194-017-0390-9 ↗
36. LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated via spectral photon-counting CT imaging: a proof-of-concept research10.1039/D2TB02416K ↗
37. Surface modification effect on contrast agent efficiency for X-ray based spectral photon-counting scanner/luminescence imaging: from fundamental study to in vivo proof of concept10.1039/D3NR03710J ↗
38. Ytterbium nanoparticle contrast agents for conventional and spectral photon-counting CT and their applications for hydrogel imaging10.1021/acsami.2c12354 ↗
39. Nanoparticulated bimodal contrast agent for ultra-high-field magnetic resonance imaging and spectral X-ray computed tomography10.1021/acs.inorgchem.4c01114 ↗
40. Bicolor K-edge spectral photon-counting CT imaging for the diagnosis of thoracic endoleaks: a dynamic phantom study10.1016/j.diii.2022.12.003 ↗
41. Element-specific spectral imaging of multiple contrast agents: a phantom study10.1088/1748-0221/13/02/T02001 ↗
42. Multifunctional Poly(Acrylic Acid)-Coated EuBiGd2O3 nanocomposite as an effective contrast agent in spectral photon counting CT, MRI, and fluorescence imaging10.2147/IJN.S506187 ↗
43. Gold nanoparticles spectral CT imaging and limit of detectability in a new materials contrast-detail phantom10.1016/j.ejmp.2024.103326 ↗
44. Assessment of material identification errors, image quality, and radiation doses using small animal spectral photon-counting CT10.1109/TRPMS.2020.3003260 ↗
45. Dual-contrast biphasic liver imaging with iodine and gadolinium using photon-counting detector computed tomography: an exploratory animal study10.1097/RLI.0000000000000815 ↗
46. Dhawan · 2023
47. Co-Delivery of methotrexate and nanohydroxyapatite with polyethylene glycol polymers for chemotherapy of osteosarcoma10.3390/mi14040757 ↗
48. Near-infrared-driven upconversion nanoparticles with photocatalysts through water-splitting towards cancer treatment10.1039/D3TB01066J ↗
49. Different targeting ligands-mediated drug delivery systems for tumor therapy10.3390/pharmaceutics16020248 ↗
50. Advances in targeting the folate receptor in the treatment/imaging of cancers10.1039/C7SC04004K ↗
51. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier10.1016/j.biopha.2018.12.008 ↗
52. Folate receptor-α targeted delivery of berberine via folate-functionalized bovine serum albumin nanocarriers to enhance intracellular internalization and suppress 3D spheroid formation as a pioneering therapeutic modality for glioblastoma10.1039/D5TB01715G ↗
53. Folic acid, folate conjugates and folate receptors: novel applications in imaging of cancer and inflammation-related conditions10.2147/CMAR.S549662 ↗
54. Serum albumin nanoparticles: ligand functionalization for enhanced targeted therapeutics in precision medicine10.1016/j.medidd.2025.100218 ↗
55. The uniqueness of Albumin as a carrier in nanodrug delivery10.1021/acs.molpharmaceut.1c00046 ↗
56. Hemato-biochemical profile of Turkey birds selected from Sherpur district of Bangladesh
57. pH-induced conformational isomerization of bovine serum albumin studied by extrinsic and intrinsic protein fluorescence10.1007/s10895-010-0781-3 ↗
58. MARS spectral molecular imaging of lamb tissue: data collection and image analysis10.1088/1748-0221/9/02/P02005 ↗
59. Assessment of material identification and quantification in the presence of metals using spectral photon counting CT10.1371/journal.pone.0308658 ↗
60. Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy10.1186/s12951-024-03008-z ↗
61. Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer10.1186/s13550-025-01345-0 ↗
62. Chemistry of MRI contrast agents: current challenges and new frontiers10.1021/acs.chemrev.8b00363 ↗
63. Magnetic nanoparticle-polyelectrolyte interaction: a layered approach for biomedical applications10.1166/jnn.2008.AN02 ↗
64. Size-dependent glioblastoma targeting by polymeric nanoruler with prolonged blood circulation10.1021/acs.bioconjchem.4c00235 ↗
65. Clearance of nanoparticles from blood: effects of hydrodynamic size and surface coatings10.1039/D3EN00812F ↗
66. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles10.1016/j.jconrel.2013.09.013 ↗
67. Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system
68. Systematic FTIR spectroscopy study of the secondary structure changes in human serum albumin under various denaturation conditions10.3390/biom9080359 ↗
69. Folic-acid-conjugated thermoresponsive polymeric particles for targeted delivery of 5-Fluorouracil to CRC cells10.3390/ijms24021364 ↗
70. Synergistic effect of folate-conjugated polymers and 5-fluorouracil in the treatment of colon cancer10.1186/s12645-021-00104-9 ↗
71. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery10.1016/j.jcis.2010.10.054 ↗
72. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy10.1016/j.biomaterials.2011.08.086 ↗
73. Engineered BSA nanoparticles: synthesis, drug loading, and advanced characterization10.1007/978-1-0716-4434-8 ↗
74. In vitro hemolysis: guidance for the pharmaceutical scientist10.1002/jps.20627 ↗
75. pH-sensitive curcumin conjugated micelles for tumor triggered drug delivery10.1080/09205063.2020.1833815 ↗
76. K-Edge imaging in spectral photon-counting computed tomography: a benchtop system study
77. High atomic number nanoparticles to enhance spectral CT imaging aspects10.1039/D3MA00231D ↗
78. Delft university of technology recent advances in lanthanide-based nanoparticle contrast agents for magnetic resonance imaging synthesis , characterization , and applications OpenNano recent advances in lanthanide-based nanoparticle contrast agents for ma
79. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths10.1097/01.rli.0000184756.66360.d3 ↗
80. Hydrophilic biocompatible Poly(Acrylic acid-co-maleic acid) polymer as a surface-coating ligand of ultrasmall Gd(2)O(3) nanoparticles to obtain a high r(1) value and T(1) MR images10.3390/diagnostics11010002 ↗
81. Polyaspartic acid-coated paramagnetic gadolinium oxide nanoparticles as a dual-modal T1 and T2 magnetic resonance imaging contrast agent10.3390/app11178222 ↗